ARCHIVES

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

This article is from The Cancer Letter archive.

Vol. 38 No. 18 | May 4, 2012

Download PDF Visit The Full Archive

Related Articles

Foundation Offers Funding.

July 4, 2003

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended

February 24, 2012

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

May 9, 1997

Editorial: Ambiance Through Exclusion

May 20, 1994

New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million

June 25, 1982